Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccine

Simple item page
dc.contributor.authorSindhu, Meenakshien_US
dc.contributor.authorBamotra, Ravi Kanten_US
dc.contributor.authorSingh, Sukhdeven_US
dc.date.accessioned2023-08-25T06:36:08Z
dc.date.available2023-08-25T06:36:08Z
dc.date.issued2023-02
dc.description.abstractWe case of acute bilateral central serous chorioretinopathy (CSCR) after receiving the first dose of Covishield vaccine in a young, otherwise healthy male with no associated risk factors.en_US
dc.identifier.affiliationsVivek Mission Eye Hospital, Bathinda, Punjab, Indiaen_US
dc.identifier.citationSindhu Meenakshi, Bamotra Ravi Kant, Singh Sukhdev. Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccine. Indian Journal of Ophthalmology. 2023 Feb; 71(2): 666-668en_US
dc.identifier.issn1998-3689
dc.identifier.issn0301-4738
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/224867
dc.languageenen_US
dc.publisherAll India Ophthalmological Societyen_US
dc.relation.issuenumber2en_US
dc.relation.volume71en_US
dc.source.urihttps://doi.org/10.4103/ijo.IJO_1629_22en_US
dc.subjectCOVID?19en_US
dc.subjectCovishield vaccineen_US
dc.subjectCSCRen_US
dc.titleAcute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccineen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
IJO2023v71n2p666.pdf
Size:
2.03 MB
Format:
Adobe Portable Document Format
Download
Collections
Indian Journal of Ophthalmology